A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco D, Zhang M, Dawkins K November 20, 2017 | 10.4244/EIJ-D-17-00271
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial Gao R, Xu B, Lansky A, Yang Y, Ma C-S, Han Y-L, Chen S-L, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M May 21, 2013 | 10.4244/EIJV9I1A12
New issue Discover the Special Edition on valvular heart disease prepared for PCR London Valves (3D-TEE model - Optimal implantation) November 15, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial Medical device regulation in Europe – what is changing and how can I become more involved? October 18, 2019